Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3243]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Treating ALL patients with T cells targeted for CD19
Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA
Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )
8 Dec 2013
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in...
Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
T cells engineered with chimeric antigen receptor targeting CD19 produce...
Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Removal of alpha/beta T cells and of CD19 B cells in children With acute...
Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy
Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )
8 Dec 2013
Transplantation and short telomeres increase the risk of cognitive impairment
Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California
Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California )
8 Dec 2013
Study of the efficacy and safety of siltuximab, an anti-interleukin-6...
Dr Raymond Wong - Chinese University of Hong Kong
Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease ( Dr Raymond Wong - Chinese University of Hong Kong )
8 Dec 2013
Results from the randomised phase III Children’s Oncology Group (COG) trial...
Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013
Final stage II results of the CLL11 trial
Dr Valentin Goede - University of Cologne, Germany
Final stage II results of the CLL11 trial ( Dr Valentin Goede - University of Cologne, Germany )
8 Dec 2013
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause...
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
7 Dec 2013
Equality of access to transplant for ethnic minority patients
Dr Robert Lown - University College London, UK
Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - University College London, UK )
7 Dec 2013
Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
7 Dec 2013
Encouraging outcomes in older patients following nonmyeloablative...
Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation ( Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
7 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation